First-line nivolumab plus ipilimumab or chemotherapy versus chemotherapy alone in advanced esophageal squamous cell carcinoma: a Japanese subgroup analysis of open-label, phase 3 trial (CheckMate 648/ONO-4538-50).

Ken KatoYuichiro DokiTakashi OgataSatoru MotoyamaHisato KawakamiMasaki UenoTakashi KojimaYasuhiro ShirakawaMorihito OkadaRyu IshiharaYutaro KubotaCarlos Amaya-ChanagaTian ChenYasuhiro MatsumuraYuko Kitagawa

Published in: Esophagus : official journal of the Japan Esophageal Society (2022)

NCT03143153.

Keyphrases

open label
locally advanced
phase iii
clinical trial
phase ii study
squamous cell carcinoma
phase ii
study protocol
randomized controlled trial
radiation therapy
double blind